FMS' acquisitions, partnerships and global reach fuel growth, even as rising costs and optimization efforts weigh on ...

If you are wondering whether Fresenius Medical Care is attractively priced or not, this article walks through the key numbers ...

Fresenius Medical Care recently accelerated the second tranche of its €1.00 billion share buyback program, committing about ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal disease, will accelerate its share buyback program and start the repurchase of the second ...

Fresenius Medical Care (XTRA:FME) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months, alongside positive ...

Detailed price information for Fresenius Medical Care Ag ADR (FMS-N) from The Globe and Mail including charting and trades.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

A Northern Lehigh man is in urgent need of a kidney donation. Deborah Sell said Wednesday night on social media that her ...

CorMedix’s CRMD lead product, DefenCath (taurolidine plus heparin), is the company’s primary source of revenues. DefenCath ...

Fresenius Kabi, part of the healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has been certified by the Top Employers Institute ...

Fresenius Kabi and TQ Therapeutics, have entered into a strategic-development agreement under which Fresenius Kabi has an ...

Fresenius Medical Care announced today that it plans to accelerate its $1.2 billion (€1 billion) share buyback program.